One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The National Kidney Foundation’s Efforts to Improve and Increase Patient-Centered CKD Research
Teri Browne/Derek Forfang/Samuel Bethel/Jessica Joseph/Laura Brereton/Kelli Collins Damron
doi : 10.1053/j.ajkd.2020.11.008
VOLUME 77, ISSUE 4, P471-473, APRIL 01, 2021
World Kidney Day 2021: Living Well With Kidney Disease by Patient and Care Partner Empowerment—Kidney Health for Everyone Everywhere
Kamyar Kalantar-Zadeh, MD, MPH, PhD /Philip Kam-Tao Li/Ekamol Tantisattamo, MD, MPH/Latha Kumaraswami/Vassilios Liakopoulos/Siu-Fai Lui/Ifeoma Ulasi/Sharon Andreoli/Alessandro Balducci, MD/Sophie Dupuis, MA/Tess Harris/Anne Hradsky/Richard Knight/Sajay Kumar/Maggie Ng/Alice Poidevin/Gamal Saadi/Allison Tong
doi : 10.1053/j.ajkd.2021.01.001
VOLUME 77, ISSUE 4, P474-477, APRIL 01, 2021
Urate Lowering With Combination Therapy in CKD: Reason for Optimism or Einstein’s Definition of Insanity?
Diana I. Jalal/Glenn M. Chertow
doi : 10.1053/j.ajkd.2020.11.007
VOLUME 77, ISSUE 4, P478-480, APRIL 01, 2021
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial
Austin G. Stack/Nalina Dronamraju/Joanna Parkinson/Susanne Johansson/Eva Johnsson/Fredrik Erlandsson/Robert Terkeltaub
doi : 10.1053/j.ajkd.2020.09.009
VOLUME 77, ISSUE 4, P481-489, APRIL 01, 2021
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study
Dennis G. Moledina/Michael Simonov/Yu Yamamoto/Jameel Alausa/Tanima Arora/Aditya Biswas/Lloyd G. Cantley/Lama Ghazi/Jason H. Greenberg/Monique Hinchcliff/Chenxi Huang/Sherry G. Mansour/Melissa Martin/Aldo Peixoto/Wade Schulz/Labeebah Subair/Jeffrey M. Testani/Ugochukwu Ugwuowo/Patrick Young/F. Perry Wilson
doi : 10.1053/j.ajkd.2020.12.007
VOLUME 77, ISSUE 4, P490-499.E1, APRIL 01, 2021
Inpatient Pediatric CKD Health Care Utilization and Mortality in the United States
Zubin J. Modi/Anne Waldo/David T. Selewski/Jonathan P. Troost/Debbie S. Gipson
doi : 10.1053/j.ajkd.2020.07.024
VOLUME 77, ISSUE 4, P500-508, APRIL 01, 2021
Creatinine–Cystatin C Ratio and Mortality in Patients Receiving Intensive Care and Continuous Kidney Replacement Therapy: A Retrospective Cohort Study
Chan-Young Jung/Young Su Joo/Hyung Woo Kim/Seung Hyeok Han/Tae-Hyun Yoo/Shin-Wook Kang/Jung Tak Park
doi : 10.1053/j.ajkd.2020.08.014
VOLUME 77, ISSUE 4, P509-516.E1, APRIL 01, 2021
Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review
Michael R. Rudnick/Ihab M. Wahba/Amanda K. Leonberg-Yoo/Dana Miskulin/Harold I. Litt
doi : 10.1053/j.ajkd.2020.07.012
VOLUME 77, ISSUE 4, P517-528, APRIL 01, 2021
Recommendations for Public Policy Changes to Improve Supportive Care for Seriously Ill Patients With Kidney Disease
Louis H. Diamond/Nancy C. Armistead/Dale E. Lupu/Alvin H. Moss/on behalf of theSteering Committee of the Coalition for Supportive Care of Kidney Patients
doi : 10.1053/j.ajkd.2020.09.020
VOLUME 77, ISSUE 4, P529-537, APRIL 01, 2021
Qualitative Research in CKD: How to Appraise and Interpret the Evidence
Amanda Baumgart/Jonathan C. Craig/Allison Tong
doi : 10.1053/j.ajkd.2020.12.011
VOLUME 77, ISSUE 4, P538-541, APRIL 01, 2021
Towards Consensus in Timing of Kidney Replacement Therapy for Acute Kidney Injury?
Ryann Sohaney/Lenar T. Yessayan/Michael Heung
doi : 10.1053/j.ajkd.2020.08.004
VOLUME 77, ISSUE 4, P542-545, APRIL 01, 2021
Risks of Hip and Nonvertebral Fractures in Patients With CKD
Juan Carlos Ayus, MD/Sagar U. Nigwekar, MD/Armando Luis Negri, MD
doi : 10.1053/j.ajkd.2020.10.018
VOLUME 77, ISSUE 4, P546, APRIL 01, 2021
In Reply to “Risks of Hip and Nonvertebral Fractures in Patients With CKD”
Tatiane Vilaca, MD/Syazrah Salam, MBChB/Richard Eastell, MD
doi : 10.1053/j.ajkd.2020.11.010
VOLUME 77, ISSUE 4, P546-547, APRIL 01, 2021
Variation in Best Practice Measures in Patients With Severe Hospital-Acquired Acute Kidney Injury: A Multicenter Study
Dennis G. Moledina/Olivia Belliveau/Yu Yamamoto/Tanima Arora/Kyle A. Carey/Matthew Churpek/Melissa Martin/Caitlin M. Partridge/Sherry G. Mansour/Chirag R. Parikh/Jay L. Koyner/F. Perry Wilson
doi : 10.1053/j.ajkd.2020.08.013
VOLUME 77, ISSUE 4, P547-549, APRIL 01, 2021
Erratum Regarding “SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review” (Am J Kidney Dis. 2018;72[2]:267-277)
doi : 10.1053/j.ajkd.2021.01.004
VOLUME 77, ISSUE 4, P550, APRIL 01, 2021
Erratum Regarding “KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update” (Am J Kidney Dis. 2020;75[4][suppl 2]:S1-S164)
doi : 10.1053/j.ajkd.2021.02.002
VOLUME 77, ISSUE 4, P551, APRIL 01, 2021
National Kidney Foundation 2021 Spring Clinical Meeting Abstracts April 6-10, 2021
doi : 10.1053/j.ajkd.2021.02.004
VOLUME 77, ISSUE 4, P552-566, APRIL 01, 2021
1 Chronic Kidney Disease in Texas: The Utility of Renal Genetic Testing
doi : 10.1053/j.ajkd.2021.02.006
VOLUME 77, ISSUE 4, P567, APRIL 01, 2021
2 Acute Kidney Injury After Implantation of an Antibiotic Impregnated Cement Spacer for Treatment of Periprosthetic Infection of Hip Joint
doi : 10.1053/j.ajkd.2021.02.007
VOLUME 77, ISSUE 4, P567, APRIL 01, 2021
3 No, That’s Not Grape Soda: A Case Report on Purple Urine
doi : 10.1053/j.ajkd.2021.02.008
VOLUME 77, ISSUE 4, P567, APRIL 01, 2021
4 Patterns of Potassium Binder Use Among Hospitalized Patients With Hyperkalemia and Factors Associated With Binder Use
doi : 10.1053/j.ajkd.2021.02.009
VOLUME 77, ISSUE 4, P568, APRIL 01, 2021
5 The Prevalence of Predialysis Hyperkalemia and Associated Characteristics Among Hemodialysis Patients That Utilize Dialysis: The RE-UTILIZE Study
doi : 10.1053/j.ajkd.2021.02.010
VOLUME 77, ISSUE 4, P568, APRIL 01, 2021
6 A Meta-analysis of Extracorporeal Anticoagulants in Pediatric Continuous Kidney Replacement Therapy
doi : 10.1053/j.ajkd.2021.02.011
VOLUME 77, ISSUE 4, P568, APRIL 01, 2021
7 The Use of the Renal Angina Index in Predicting Acute Kidney Injury
doi : 10.1053/j.ajkd.2021.02.012
VOLUME 77, ISSUE 4, P568-569, APRIL 01, 2021
8 Attitudes Towards and Rates of Colorectal Cancer (CRC) Screening in Inner-City Chronic Kidney Disease (CKD) or Kidney Transplant (KTx) Patients
doi : 10.1053/j.ajkd.2021.02.013
VOLUME 77, ISSUE 4, P569, APRIL 01, 2021
9 Intoxication With Fireball Whiskey Leading to Severe Lactic Acidosis in Two Patients
doi : 10.1053/j.ajkd.2021.02.014
VOLUME 77, ISSUE 4, P569, APRIL 01, 2021
10 IgA Nephropathy Associated With Psoriasis and Lymphoma
doi : 10.1053/j.ajkd.2021.02.015
VOLUME 77, ISSUE 4, P569-570, APRIL 01, 2021
11 Acute Rejection Among Kidney Transplant Recipients During COVID-19 Pandemic: Alarming Phenomena
doi : 10.1053/j.ajkd.2021.02.016
VOLUME 77, ISSUE 4, P570, APRIL 01, 2021
12 A Rare Case of Atypical Hemolytic Uremic Syndrome and Primary Membranous Nephropathy With Novel Findings
doi : 10.1053/j.ajkd.2021.02.017
VOLUME 77, ISSUE 4, P570, APRIL 01, 2021
13 Granulomatous Interstitial Nephritis in a Patient With CLL
doi : 10.1053/j.ajkd.2021.02.018
VOLUME 77, ISSUE 4, P570-571, APRIL 01, 2021
14 Clinical Significance of Kallikrein Protein (KLK1) Levels Following DM199 in Patients With Diabetes and Chronic Kidney Disease
doi : 10.1053/j.ajkd.2021.02.019
VOLUME 77, ISSUE 4, P571, APRIL 01, 2021
15 REDUX: A Multicenter, Open-label Study of DM199 (Recombinant Human Tissue Kallikrein-1) in Patients With Stage II or III Chronic Kidney Disease
doi : 10.1053/j.ajkd.2021.02.020
VOLUME 77, ISSUE 4, P571, APRIL 01, 2021
16 Autoimmune Encephalitis: A Rare Cause of SIADH
doi : 10.1053/j.ajkd.2021.02.021
VOLUME 77, ISSUE 4, P571-572, APRIL 01, 2021
17 Electrolyte Abnormalities Associated With Atezolizumab: A Systematic Review of Literature
doi : 10.1053/j.ajkd.2021.02.022
VOLUME 77, ISSUE 4, P572, APRIL 01, 2021
18 Bacteremia With Non-O1, Non-O139 Vibrio Cholera in Two Hemodialysis Patients
doi : 10.1053/j.ajkd.2021.02.023
VOLUME 77, ISSUE 4, P572, APRIL 01, 2021
19 Posttransplant Idiopathic Immune Complex Glomerulonephritis
doi : 10.1053/j.ajkd.2021.02.024
VOLUME 77, ISSUE 4, P572-573, APRIL 01, 2021
20 Cardiorenal Syndrome in Pulmonary Arterial Hypertension
doi : 10.1053/j.ajkd.2021.02.025
VOLUME 77, ISSUE 4, P573, APRIL 01, 2021
21 ABCs of Kidney Disease: An Interactive Patient Education Program
doi : 10.1053/j.ajkd.2021.02.026
VOLUME 77, ISSUE 4, P573, APRIL 01, 2021
22 Examining Post-donation Outcomes in Hispanic/Latinx Living Kidney Donors in the United States: A Systematic Review
doi : 10.1053/j.ajkd.2021.02.027
VOLUME 77, ISSUE 4, P573, APRIL 01, 2021
23 A Bloody Disguise: IgA Nephropathy Relapse After SARS-CoV-2 Infection
doi : 10.1053/j.ajkd.2021.02.028
VOLUME 77, ISSUE 4, P574, APRIL 01, 2021
24 Improved Dialysis Symptom Index with Tablo Thrice Weekly Dialysis
doi : 10.1053/j.ajkd.2021.02.029
VOLUME 77, ISSUE 4, P574, APRIL 01, 2021
25 Efficacy of Voclosporin Across Lupus Nephritis Biopsy Classes: Pooled Data From the AURORA and AURA-LV Trials
doi : 10.1053/j.ajkd.2021.02.030
VOLUME 77, ISSUE 4, P574, APRIL 01, 2021
26 Thrombotic Microangiopathy From APLS Nephropathy Responsive to Therapeutic Plasma Exchange: A Case Report
doi : 10.1053/j.ajkd.2021.02.031
VOLUME 77, ISSUE 4, P575, APRIL 01, 2021
27 Cyclosporin-Induced Thrombocytopenia in a Kidney Transplant Recipient: Case Report
doi : 10.1053/j.ajkd.2021.02.032
VOLUME 77, ISSUE 4, P575, APRIL 01, 2021
28 Desperate Times Call for Desperate Measurement: Reversing Tacrolimus in a Critically Ill Patient
doi : 10.1053/j.ajkd.2021.02.033
VOLUME 77, ISSUE 4, P575, APRIL 01, 2021
29 Raising the Bar: Highest Serum Creatinine Reported
doi : 10.1053/j.ajkd.2021.02.034
VOLUME 77, ISSUE 4, P575-576, APRIL 01, 2021
30 Impact of Finerenone on Chronic Kidney Disease Progression in Black or African American Patients With Type 2 Diabetes–Analysis of the FIDELIO-DKD study
doi : 10.1053/j.ajkd.2021.02.035
VOLUME 77, ISSUE 4, P576, APRIL 01, 2021
31 Reflex Anuria Post Pelvic Surgery
doi : 10.1053/j.ajkd.2021.02.036
VOLUME 77, ISSUE 4, P576, APRIL 01, 2021
32 Changes in Diet Composition in US Adults With CKD
doi : 10.1053/j.ajkd.2021.02.037
VOLUME 77, ISSUE 4, P576-577, APRIL 01, 2021
33 Mycobacterium Abscessus Peritoneal Dialysis Exit Site Infection
doi : 10.1053/j.ajkd.2021.02.038
VOLUME 77, ISSUE 4, P577, APRIL 01, 2021
34 IgA-Dominant Glomerulonephritis With a Membranoproliferative Pattern of Injury in a Patient With Cirrhosis
doi : 10.1053/j.ajkd.2021.02.039
VOLUME 77, ISSUE 4, P577, APRIL 01, 2021
35 Refractory Hypokalemia Due to Posaconazole Induced Apparent Mineralocorticoid Excess
doi : 10.1053/j.ajkd.2021.02.040
VOLUME 77, ISSUE 4, P577-578, APRIL 01, 2021
36 Opportunities to Raise Awareness About Gout and Chronic Kidney Disease: Findings From An Online Survey
doi : 10.1053/j.ajkd.2021.02.041
VOLUME 77, ISSUE 4, P578, APRIL 01, 2021
37 Predicting Decline in Residual Renal Urea Clearance via Machine Learning
doi : 10.1053/j.ajkd.2021.02.042
VOLUME 77, ISSUE 4, P578, APRIL 01, 2021
38 Levetiracetam Associated High Anion Gap Metabolic Acidosis (HAGMA) in End Stage Renal Disease
doi : 10.1053/j.ajkd.2021.02.043
VOLUME 77, ISSUE 4, P578, APRIL 01, 2021
39 A Rare Case of Secondary Retroperitoneal Fibrosis Due to Endometrial Cancer
doi : 10.1053/j.ajkd.2021.02.044
VOLUME 77, ISSUE 4, P578-579, APRIL 01, 2021
40 Cloak, then Dagger: A Case Series of Disguised Disseminated Nocardia Infection
doi : 10.1053/j.ajkd.2021.02.045
VOLUME 77, ISSUE 4, P579, APRIL 01, 2021
41 Nasogastric Tube Dose Delivery of Veverimer, a Non-absorbed Polymer in Development for Patients with CKD and Metabolic Acidosis
doi : 10.1053/j.ajkd.2021.02.046
VOLUME 77, ISSUE 4, P579, APRIL 01, 2021
42 Mantle Cell Lymphoma and Sero-Negative Pauci Immune Crescentic Glomerulonephritis
doi : 10.1053/j.ajkd.2021.02.047
VOLUME 77, ISSUE 4, P579-580, APRIL 01, 2021
43 Hidden Gems: Rare Case of Curcumin-Turmeric Related Acute Oxalate Nephropathy
doi : 10.1053/j.ajkd.2021.02.048
VOLUME 77, ISSUE 4, P580, APRIL 01, 2021
44 Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease: NEUTRALIZE Study
doi : 10.1053/j.ajkd.2021.02.049
VOLUME 77, ISSUE 4, P580, APRIL 01, 2021
45 Ifosfamide-Induced Renal Disease
doi : 10.1053/j.ajkd.2021.02.050
VOLUME 77, ISSUE 4, P580, APRIL 01, 2021
46 Evaluation of Monoclonal Antibody and Immune Globulin Administration With Therapeutic Plasma Exchange
doi : 10.1053/j.ajkd.2021.02.051
VOLUME 77, ISSUE 4, P580-581, APRIL 01, 2021
47 Effectiveness of Ultrasound-Guided Cannulation of AVF on Infiltration Rates: A Single-Center Quality Improvement Study
doi : 10.1053/j.ajkd.2021.02.052
VOLUME 77, ISSUE 4, P581, APRIL 01, 2021
48 Analyzing Acute Kidney Injury (AKI) Trends at Whiteriver Indian Hospital
doi : 10.1053/j.ajkd.2021.02.053
VOLUME 77, ISSUE 4, P581, APRIL 01, 2021
49 Uromodulin for Prognosis of Kidney Disease After a Biopsy
doi : 10.1053/j.ajkd.2021.02.054
VOLUME 77, ISSUE 4, P581-582, APRIL 01, 2021
50 A Case of MPO-ANCA Vasculitis With Coexisting IgA Nephropathy
doi : 10.1053/j.ajkd.2021.02.055
VOLUME 77, ISSUE 4, P582, APRIL 01, 2021
51 Palbociclib Causing Enteric Hyperoxaluria Induced AKI
doi : 10.1053/j.ajkd.2021.02.056
VOLUME 77, ISSUE 4, P582, APRIL 01, 2021
52 Content Analysis of Patient Educational Materials for Hypertension
doi : 10.1053/j.ajkd.2021.02.057
VOLUME 77, ISSUE 4, P582-583, APRIL 01, 2021
53 A Systematic Review of the Incidence and Outcomes of Acute Kidney Injury in COVID-19
doi : 10.1053/j.ajkd.2021.02.058
VOLUME 77, ISSUE 4, P583, APRIL 01, 2021
54 Microscopic Polyangiitis With Pulmonary-renal Syndrome Following SARS-CoV-2 Infection
doi : 10.1053/j.ajkd.2021.02.059
VOLUME 77, ISSUE 4, P583, APRIL 01, 2021
55 Trial Design for Phase 3 FALCON: Evaluation of the Safety, Tolerability, and Efficacy of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
doi : 10.1053/j.ajkd.2021.02.060
VOLUME 77, ISSUE 4, P583, APRIL 01, 2021
56 Comparing Alport Syndrome and Anti-Glomerular Basement Membrane Disease in Two Young Women Presenting with Acute Kidney Injury and Proteinuria
doi : 10.1053/j.ajkd.2021.02.061
VOLUME 77, ISSUE 4, P583-584, APRIL 01, 2021
57 Monoclonal Gammopathy of Renal Significance Leading to Longstanding Hypertension and Nephrotic Syndrome
doi : 10.1053/j.ajkd.2021.02.062
VOLUME 77, ISSUE 4, P584, APRIL 01, 2021
58 Prompt Diagnosis and Intervention for Acyclovir-Associated Acute Kidney Injury
doi : 10.1053/j.ajkd.2021.02.063
VOLUME 77, ISSUE 4, P584-585, APRIL 01, 2021
59 Refractory Secondary Hypertension Leading to Acute Renal Failure, Resolved by Renal Artery Angiography
doi : 10.1053/j.ajkd.2021.02.064
VOLUME 77, ISSUE 4, P585, APRIL 01, 2021
60 Challenge of Treating Severe Hypernatremia in Diabetic Ketoacidosis and Acute Kidney Injury Using Continuous Venovenous Hemofiltration
doi : 10.1053/j.ajkd.2021.02.065
VOLUME 77, ISSUE 4, P585-586, APRIL 01, 2021
61 Early Experience With Renal Genetic Testing in an Internal Medicine Clinic
doi : 10.1053/j.ajkd.2021.02.066
VOLUME 77, ISSUE 4, P586, APRIL 01, 2021
62 Non-Dilated Obstructive Nephropathy
doi : 10.1053/j.ajkd.2021.02.067
VOLUME 77, ISSUE 4, P586, APRIL 01, 2021
63 Risk of RBC Transfusion and Volume-Related Adverse Events in Patients With Nondialysis-Dependent Chronic Kidney Disease: Pooled Results From Roxadustat Phase 3 Studies
doi : 10.1053/j.ajkd.2021.02.068
VOLUME 77, ISSUE 4, P586, APRIL 01, 2021
64 Dialyze or Not? Case-Based Approach to a Rare Toxicity
doi : 10.1053/j.ajkd.2021.02.069
VOLUME 77, ISSUE 4, P586-587, APRIL 01, 2021
65 Bland Urine and Nephritis: A Case of Mesalamine-Induced Nephrotoxicity
doi : 10.1053/j.ajkd.2021.02.070
VOLUME 77, ISSUE 4, P587, APRIL 01, 2021
66 COVID-19–Induced Collapsing Glomerulopathy and Role of APOL1
doi : 10.1053/j.ajkd.2021.02.071
VOLUME 77, ISSUE 4, P587, APRIL 01, 2021
67 The Psychosocial Impact of COVID-19 on Home Dialysis
doi : 10.1053/j.ajkd.2021.02.072
VOLUME 77, ISSUE 4, P587, APRIL 01, 2021
68 Changes in Incidence of COVID-19 Associated AKI Over 2020
doi : 10.1053/j.ajkd.2021.02.073
VOLUME 77, ISSUE 4, P588, APRIL 01, 2021
69 An Academic Hospital’s Inpatient Dialysis Unit’s Staff and Patient Experience With Use of Tablo Hemodialysis System
doi : 10.1053/j.ajkd.2021.02.074
VOLUME 77, ISSUE 4, P588, APRIL 01, 2021
70 Reno-Pulmonary Extracorporeal Organ Support for Severe COVID-19
doi : 10.1053/j.ajkd.2021.02.075
VOLUME 77, ISSUE 4, P588, APRIL 01, 2021
71 Addressing Kidney Disease Educational Gaps for Hispanic Immigrants Receiving Emergency-Only Dialysis
doi : 10.1053/j.ajkd.2021.02.076
VOLUME 77, ISSUE 4, P588-589, APRIL 01, 2021
72 COVID-19–Associated Minimal Change Disease Nephrotic Syndrome
doi : 10.1053/j.ajkd.2021.02.077
VOLUME 77, ISSUE 4, P589, APRIL 01, 2021
73 A Rare Case of Exenatide–Induced Acute Interstitial Nephritis
doi : 10.1053/j.ajkd.2021.02.078
VOLUME 77, ISSUE 4, P589, APRIL 01, 2021
74 Improving Patient Compliance in an Outpatient Hemodialysis Unit
doi : 10.1053/j.ajkd.2021.02.079
VOLUME 77, ISSUE 4, P589-590, APRIL 01, 2021
75 Implementing a Virtual Nephrology Panel for Tolvaptan Use in Patients With ADPKD
doi : 10.1053/j.ajkd.2021.02.080
VOLUME 77, ISSUE 4, P590, APRIL 01, 2021
76 Acute Lymphoblastic Leukemia (ALL) Presenting as Spontaneous Tumor Lysis Syndrome With Acute Kidney Injury (AKI) Requiring Hemodialysis (HD) in an Elderly Patient
doi : 10.1053/j.ajkd.2021.02.081
VOLUME 77, ISSUE 4, P590, APRIL 01, 2021
77 A Case of Anuria and Stable Kidney Function
doi : 10.1053/j.ajkd.2021.02.082
VOLUME 77, ISSUE 4, P590-591, APRIL 01, 2021
78 Fabry Nephropathy: Better Late Than Never
doi : 10.1053/j.ajkd.2021.02.083
VOLUME 77, ISSUE 4, P591, APRIL 01, 2021
79 Proteinuria in an HIV Patient: A Rare Case of Dual Diagnoses
doi : 10.1053/j.ajkd.2021.02.084
VOLUME 77, ISSUE 4, P591, APRIL 01, 2021
80 Anti-Brush Border Antibody Disease
doi : 10.1053/j.ajkd.2021.02.085
VOLUME 77, ISSUE 4, P591, APRIL 01, 2021
81 Congophilic Fibrillary Glomerulonephritis in a Young Female
doi : 10.1053/j.ajkd.2021.02.086
VOLUME 77, ISSUE 4, P591-592, APRIL 01, 2021
82 Hypernatremia in Three Ways
doi : 10.1053/j.ajkd.2021.02.087
VOLUME 77, ISSUE 4, P592, APRIL 01, 2021
83 Masquerading Mass After Kidney Transplant
doi : 10.1053/j.ajkd.2021.02.088
VOLUME 77, ISSUE 4, P592, APRIL 01, 2021
84 Geographic Variations in Kidney Function Testing Among Patients with Type 2 Diabetes (T2D)
doi : 10.1053/j.ajkd.2021.02.089
VOLUME 77, ISSUE 4, P592-593, APRIL 01, 2021
85 Analyzing Acute Kidney Injury and Electrolyte Abnormalities in Patients Who Underwent CAR-T Therapy
doi : 10.1053/j.ajkd.2021.02.090
VOLUME 77, ISSUE 4, P593, APRIL 01, 2021
86 Are All Osmoles Created Equal?: A Case of Post Obstructive Diuresis (POD)
doi : 10.1053/j.ajkd.2021.02.091
VOLUME 77, ISSUE 4, P593, APRIL 01, 2021
87 Long-term Safety and Efficacy of Difelikefalin in Patients With Chronic Kidney Disease–Associated Pruritus: Analysis From KALM-1 and KALM-2
doi : 10.1053/j.ajkd.2021.02.092
VOLUME 77, ISSUE 4, P593-594, APRIL 01, 2021
88 New Mechanistic Understanding of Phosphate Absorption and Implications for Phosphate Management
doi : 10.1053/j.ajkd.2021.02.093
VOLUME 77, ISSUE 4, P594, APRIL 01, 2021
89 Effect of Oral Sodium Bicarbonate on Calcium-Phosphate Nephrolithiasis Risk in Chronic Kidney Disease: A Secondary Analysis of the BASE Pilot Trial
doi : 10.1053/j.ajkd.2021.02.094
VOLUME 77, ISSUE 4, P594, APRIL 01, 2021
90 SARS-CoV-2 Not Detected in Peritoneal Effluent in COVID-19 End-Stage Kidney Disease (ESKD) Peritoneal Dialysis Patient
doi : 10.1053/j.ajkd.2021.02.095
VOLUME 77, ISSUE 4, P595, APRIL 01, 2021
91 Thigh Pain in a Patient on Peritoneal Dialysis
doi : 10.1053/j.ajkd.2021.02.096
VOLUME 77, ISSUE 4, P595, APRIL 01, 2021
92 Acetaminophen-Induced Renal Tubular Injury With Concurrent Hepatotoxicity: A Case Report
doi : 10.1053/j.ajkd.2021.02.097
VOLUME 77, ISSUE 4, P595, APRIL 01, 2021
93 Using Super-resolution Ultrasound to Detect Microvascular Changes in Chronic Kidney Disease in Human Subjects
doi : 10.1053/j.ajkd.2021.02.098
VOLUME 77, ISSUE 4, P595-596, APRIL 01, 2021
94 Lupus-like Immune Complex GN in a Cancer Patient on PD1-Inhibitor Therapy
doi : 10.1053/j.ajkd.2021.02.099
VOLUME 77, ISSUE 4, P596, APRIL 01, 2021
95 Postpartum Blood Pressure and Effect of Non-Steroidal Anti-Inflammatory Drugs
doi : 10.1053/j.ajkd.2021.02.100
VOLUME 77, ISSUE 4, P596, APRIL 01, 2021
96 Hypercalcemia of Immobilization: An Often-Overlooked Disorder
doi : 10.1053/j.ajkd.2021.02.101
VOLUME 77, ISSUE 4, P596-597, APRIL 01, 2021
97 Incidental Finding of Unilateral Renal Cystic Disease
doi : 10.1053/j.ajkd.2021.02.102
VOLUME 77, ISSUE 4, P597, APRIL 01, 2021
98 Severe Hypophosphatemia After Iron Infusion: A Serious Complication
doi : 10.1053/j.ajkd.2021.02.103
VOLUME 77, ISSUE 4, P597, APRIL 01, 2021
99 Greater Effect on Total Kidney Volume (TKV) With Tolvaptan (TOL) Despite Placebo (PBO)-treated Subjects Reaching Similar Spot Urine Osmolality 3(Uosm) Potentially Due to Increased Water Consumption in ADPKD: Post-hoc Analysis of TEMPO 3:4
doi : 10.1053/j.ajkd.2021.02.104
VOLUME 77, ISSUE 4, P597-598, APRIL 01, 2021
100 Grocery Shopping Patterns and Food Scarcity During the COVID-19 Pandemic in Inner-City Patients With Chronic Kidney Disease (CKD)
doi : 10.1053/j.ajkd.2021.02.105
VOLUME 77, ISSUE 4, P598, APRIL 01, 2021
101 A Case Report of Type 1 Cryoglobulinemia
doi : 10.1053/j.ajkd.2021.02.106
VOLUME 77, ISSUE 4, P598, APRIL 01, 2021
102 Patient With COVID-19 Related Collapsing Glomerulopathy
doi : 10.1053/j.ajkd.2021.02.107
VOLUME 77, ISSUE 4, P598-599, APRIL 01, 2021
103 DAG SA NKF 2020 Submission
doi : 10.1053/j.ajkd.2021.02.108
VOLUME 77, ISSUE 4, P599, APRIL 01, 2021
104 Hemorrhagic Fungal Cystitis and Obstructive Acute Kidney Injury Associated With Empagliflozin and Secukinumab
doi : 10.1053/j.ajkd.2021.02.109
VOLUME 77, ISSUE 4, P599, APRIL 01, 2021
105 Aquapheresis for Life-Threatening Cardio-Respiratory Failure
doi : 10.1053/j.ajkd.2021.02.110
VOLUME 77, ISSUE 4, P599-600, APRIL 01, 2021
106 Hypermagnesaemia in a Patient With Pneumoperitoneum
doi : 10.1053/j.ajkd.2021.02.111
VOLUME 77, ISSUE 4, P600, APRIL 01, 2021
107 Tenofovir-Induced Distal RTA and Nephrogenic DI
doi : 10.1053/j.ajkd.2021.02.112
VOLUME 77, ISSUE 4, P600, APRIL 01, 2021
108 Attitudes Towards Healthcare and the COVID-19 Vaccine in an Inner-City Population of Chronic Kidney Disease (CKD) and Family Medicine (FM) Patients
doi : 10.1053/j.ajkd.2021.02.113
VOLUME 77, ISSUE 4, P600, APRIL 01, 2021
109 Baclofen Neurotoxicity
doi : 10.1053/j.ajkd.2021.02.114
VOLUME 77, ISSUE 4, P600-601, APRIL 01, 2021
110 24hr and Random Spot Urine Collections Were Comparable in Assessing Oxalate Excretion and Response to Treatment in Primary Hyperoxaluria Type 1
doi : 10.1053/j.ajkd.2021.02.115
VOLUME 77, ISSUE 4, P601, APRIL 01, 2021
111 Relationship of Comorbidities and COVID-19 to Male Sexual Performance in Patients With Chronic Kidney Disease (CKD)
doi : 10.1053/j.ajkd.2021.02.116
VOLUME 77, ISSUE 4, P601, APRIL 01, 2021
112 ESRD Network-Level Variation in Racial/Ethnic and Sex Disparities in Renal Transplant Waitlisting
doi : 10.1053/j.ajkd.2021.02.117
VOLUME 77, ISSUE 4, P601-602, APRIL 01, 2021
113 The Impact of Removing the eGFR Race Coefficient on CKD Care Practices Among Black Veterans Receiving Care in US
doi : 10.1053/j.ajkd.2021.02.118
VOLUME 77, ISSUE 4, P602, APRIL 01, 2021
114 Incidence and Risk Factors of Venous Thromboembolism in ANCA-Associated Vasculitis: A Meta-analysis and Meta-regression
doi : 10.1053/j.ajkd.2021.02.119
VOLUME 77, ISSUE 4, P602, APRIL 01, 2021
115 Missed Euglycemic DKA With SGLT2 Inhibitor
doi : 10.1053/j.ajkd.2021.02.120
VOLUME 77, ISSUE 4, P603, APRIL 01, 2021
116 Making a Genetic Diagnosis in an Elderly Female
doi : 10.1053/j.ajkd.2021.02.121
VOLUME 77, ISSUE 4, P603, APRIL 01, 2021
117 Autosomal Dominant Polycystic Kidney Disease: Age of Onset of End-Stage Kidney Disease by Race/Ethnicity
doi : 10.1053/j.ajkd.2021.02.122
VOLUME 77, ISSUE 4, P603, APRIL 01, 2021
118 A Case of Concurrent HELLP and Pregnancy Associated Atypical HUS (aHUS) During Postpartum Period
doi : 10.1053/j.ajkd.2021.02.123
VOLUME 77, ISSUE 4, P603-604, APRIL 01, 2021
119 Central Diabetes Insipidus as an Early Sign of Acute Myeloid Leukemia
doi : 10.1053/j.ajkd.2021.02.124
VOLUME 77, ISSUE 4, P604, APRIL 01, 2021
120 Emphysematous Pyelonephritis in a Kidney Transplant Recipient
doi : 10.1053/j.ajkd.2021.02.125
VOLUME 77, ISSUE 4, P604, APRIL 01, 2021
121 Profound Hyponatremia Secondary to SIADH in a Patient With Hepatocellular Carcinoma
doi : 10.1053/j.ajkd.2021.02.126
VOLUME 77, ISSUE 4, P604-605, APRIL 01, 2021
122 Rhabdomyolysis as the Initial Presentation of Distal (Type 1) RTA
doi : 10.1053/j.ajkd.2021.02.127
VOLUME 77, ISSUE 4, P605, APRIL 01, 2021
123 Pasteurella Multocida Peritonitis–Keep the Cat in the Bag!
doi : 10.1053/j.ajkd.2021.02.128
VOLUME 77, ISSUE 4, P605, APRIL 01, 2021
124 Delay in First Nephrologist Visit Among Newly Diagnosed ADPKD Patients
doi : 10.1053/j.ajkd.2021.02.129
VOLUME 77, ISSUE 4, P605, APRIL 01, 2021
125 Hyperacute Rejection of Kidney Transplant: Is Salvage of Graft Possible?
doi : 10.1053/j.ajkd.2021.02.130
VOLUME 77, ISSUE 4, P605-606, APRIL 01, 2021
126 Chronic Kidney Disease Nutrition Research in Sub-Saharan Africa: A Report of an Online Training Modality for Clinical Research Staff and Investigators
doi : 10.1053/j.ajkd.2021.02.131
VOLUME 77, ISSUE 4, P606, APRIL 01, 2021
127 Single Center Review of Adequacy of Renal Replacement Therapy During the Early COVID-19 Pandemic in New York City
doi : 10.1053/j.ajkd.2021.02.132
VOLUME 77, ISSUE 4, P606-607, APRIL 01, 2021
128 Attitudes Towards the COVID-19 Vaccine in an Inner-City Dialysis Population
doi : 10.1053/j.ajkd.2021.02.133
VOLUME 77, ISSUE 4, P607, APRIL 01, 2021
129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4
doi : 10.1053/j.ajkd.2021.02.134
VOLUME 77, ISSUE 4, P607, APRIL 01, 2021
130 Whole Exome Sequencing in Polycystic Kidney Disease
doi : 10.1053/j.ajkd.2021.02.135
VOLUME 77, ISSUE 4, P607-608, APRIL 01, 2021
131 An Unusual Case of Renal Failure Associated With Anaplasmosis–A Case Report
doi : 10.1053/j.ajkd.2021.02.136
VOLUME 77, ISSUE 4, P608, APRIL 01, 2021
132 Remdesivir in COVID-19 for 3 Patients With Renal Failure
doi : 10.1053/j.ajkd.2021.02.137
VOLUME 77, ISSUE 4, P608, APRIL 01, 2021
133 Glomerulonephritis Secondary to Candida Parapsilosis Endocarditis
doi : 10.1053/j.ajkd.2021.02.138
VOLUME 77, ISSUE 4, P608-609, APRIL 01, 2021
134 Rapid Renal Allograft Failure Following Recurrence of Lupus Nephritis 12 Years After Renal Transplant
doi : 10.1053/j.ajkd.2021.02.139
VOLUME 77, ISSUE 4, P609, APRIL 01, 2021
135 A Case of Gitelman Syndrome Discovered Postpartum
doi : 10.1053/j.ajkd.2021.02.140
VOLUME 77, ISSUE 4, P609, APRIL 01, 2021
136 Post-transplant Recurrence of Focal Segmental Glomerulosclerosis: Critical Appraisal and Consensus Guidelines
doi : 10.1053/j.ajkd.2021.02.141
VOLUME 77, ISSUE 4, P609-610, APRIL 01, 2021
137 Incidence of Acute Kidney Injury Among Patients Treated With CAR-T Cell Therapies: A Systematic Review and Meta-analysis
doi : 10.1053/j.ajkd.2021.02.142
VOLUME 77, ISSUE 4, P610, APRIL 01, 2021
138 A Low-Cost In-Line Device for Early Screening of Peritonitis in Peritoneal Dialysis Patients
doi : 10.1053/j.ajkd.2021.02.143
VOLUME 77, ISSUE 4, P610, APRIL 01, 2021
139 A Case Report and Literature Review of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis after Bariatric Surgery
doi : 10.1053/j.ajkd.2021.02.144
VOLUME 77, ISSUE 4, P610-611, APRIL 01, 2021
140 Sevelamer and Sodium Polystyrene Sulfonate Crystal-Induced Gastrointestinal Lesion in a Diabetic End-Stage Renal Disease Patient
doi : 10.1053/j.ajkd.2021.02.145
VOLUME 77, ISSUE 4, P611, APRIL 01, 2021
141 Spontaneous Hemorrhagic Renal Rupture in a Hemodialysis Patient
doi : 10.1053/j.ajkd.2021.02.146
VOLUME 77, ISSUE 4, P611, APRIL 01, 2021
142 Therapeutic Plasma Exchange as Treatment for Bilirubin Cast Nephropathy
doi : 10.1053/j.ajkd.2021.02.147
VOLUME 77, ISSUE 4, P611, APRIL 01, 2021
143 Preferred Style of Decision Making: Perspectives of Patients Receiving Maintenance Dialysis
doi : 10.1053/j.ajkd.2021.02.148
VOLUME 77, ISSUE 4, P612, APRIL 01, 2021
144 Attitudes Towards Receipt of a COVID-19 Vaccine in a Population of Inner-City Kidney Transplant Recipients (KTx)
doi : 10.1053/j.ajkd.2021.02.149
VOLUME 77, ISSUE 4, P612, APRIL 01, 2021
145 Oxaliplatin-Induced Hypomagnesemia
doi : 10.1053/j.ajkd.2021.02.150
VOLUME 77, ISSUE 4, P612, APRIL 01, 2021
146 Global Phase 3 Clinical Trials Assessing Efficacy and Safety of Ravulizumab in Adults and Children Who Developed Thrombotic Microangiopathy (TMA) After Hematopoietic Stem Cell Transplant (HSCT)
doi : 10.1053/j.ajkd.2021.02.151
VOLUME 77, ISSUE 4, P612-613, APRIL 01, 2021
147 Thrombotic Microangiopathy in Transplanted Kidney in an African American Male Homozygous For APOL1
doi : 10.1053/j.ajkd.2021.02.152
VOLUME 77, ISSUE 4, P613, APRIL 01, 2021
148 Advanced Practitioner Experience: Case Report on the Value of Genetic Testing in UMOD Mutation
doi : 10.1053/j.ajkd.2021.02.153
VOLUME 77, ISSUE 4, P613, APRIL 01, 2021
149 Case Report on the Utility of Genetic Testing in an Individual With CKD of Unknown Etiology
doi : 10.1053/j.ajkd.2021.02.154
VOLUME 77, ISSUE 4, P613-614, APRIL 01, 2021
150 Clinical Timeline of Decreased GFR From Hypothyroidism Caused by Amiodarone Toxicity: A Reversible Yet Underappreciated Entity
doi : 10.1053/j.ajkd.2021.02.155
VOLUME 77, ISSUE 4, P614, APRIL 01, 2021
151 Strategies to Contain COVID-19 infection in a Hospital Based Outpatient Hemodialysis Unit in the South Bronx
doi : 10.1053/j.ajkd.2021.02.156
VOLUME 77, ISSUE 4, P614, APRIL 01, 2021
152 Outcomes of Hospitalized Patients with COVID-19 and Acute Kidney Injury Requiring Renal Replacement Therapy
doi : 10.1053/j.ajkd.2021.02.157
VOLUME 77, ISSUE 4, P614-615, APRIL 01, 2021
153 A Mysterious Multisystem Disease and Renal Biopsy Revealing Concurrent IgG4-Related Disease, C3 Glomerulonephritis, and ANCA-Associated Glomerulonephritis
doi : 10.1053/j.ajkd.2021.02.158
VOLUME 77, ISSUE 4, P615, APRIL 01, 2021
154 A Mysterious Case of Hypercalcemia in Non-Uremic Calciphylaxis Patients
doi : 10.1053/j.ajkd.2021.02.159
VOLUME 77, ISSUE 4, P615, APRIL 01, 2021
155 Fanconi Syndrome Secondary to Noncrystalline Light Chain Proximal Tubulopathy in Chronic Lymphocytic Leukemia: A Rare Presentation of a Common Disease
doi : 10.1053/j.ajkd.2021.02.160
VOLUME 77, ISSUE 4, P615-616, APRIL 01, 2021
156 Illicit Anabolic Steroid-Induced Mineralocorticoid Excess
doi : 10.1053/j.ajkd.2021.02.161
VOLUME 77, ISSUE 4, P616, APRIL 01, 2021
157 Symptomatic Moderate Hyponatremia, a Lesson in Preconceived Notions
doi : 10.1053/j.ajkd.2021.02.162
VOLUME 77, ISSUE 4, P616, APRIL 01, 2021
158 Stones Without Groans: Bilateral Obstruction in the Absence of Renal Colic or Oliguria
doi : 10.1053/j.ajkd.2021.02.163
VOLUME 77, ISSUE 4, P616, APRIL 01, 2021
159 Fibrillary Glomerulonephritis Associated With Acute Aortic Dissection
doi : 10.1053/j.ajkd.2021.02.164
VOLUME 77, ISSUE 4, P616-617, APRIL 01, 2021
160 Mystery of Unresponsive Severe Metabolic Acidosis
doi : 10.1053/j.ajkd.2021.02.165
VOLUME 77, ISSUE 4, P617, APRIL 01, 2021
161 Clinical Outcomes of In-Center Hemodialysis Patients During the COVID-19 Pandemic
doi : 10.1053/j.ajkd.2021.02.166
VOLUME 77, ISSUE 4, P617, APRIL 01, 2021
162 Hepatic Glomerulosclerosis With Lipoid Deposition
doi : 10.1053/j.ajkd.2021.02.167
VOLUME 77, ISSUE 4, P617-618, APRIL 01, 2021
163 Hyperammoniaemia Resolved With Spironolactone
doi : 10.1053/j.ajkd.2021.02.168
VOLUME 77, ISSUE 4, P618, APRIL 01, 2021
164 Dialysis Access Usage in Recipients of Living Donor Kidney Transplants
doi : 10.1053/j.ajkd.2021.02.169
VOLUME 77, ISSUE 4, P618, APRIL 01, 2021
165 Knowledge and Practices Regarding COVID-19 in Inner-city Patients With Chronic Kidney Disease (CKD) or Kidney Transplant (KTx)
doi : 10.1053/j.ajkd.2021.02.170
VOLUME 77, ISSUE 4, P618-619, APRIL 01, 2021
166 Clinical Practice Gap Analysis of CKD in T2D From Identification to Diagnosis to Management
doi : 10.1053/j.ajkd.2021.02.171
VOLUME 77, ISSUE 4, P619, APRIL 01, 2021
167 Improving Knowledge and Confidence of Nephrologists Related to MRAs for CKD in T2D With Curriculum-Based Online Education
doi : 10.1053/j.ajkd.2021.02.172
VOLUME 77, ISSUE 4, P619, APRIL 01, 2021
168 Interim Assessment of Curriculum-Based Online Education Aimed at Improving Nephrologists’ Knowledge of Hyperkalemia Management
doi : 10.1053/j.ajkd.2021.02.173
VOLUME 77, ISSUE 4, P619, APRIL 01, 2021
169 Online CME is Successful at Improving Knowledge Related to Emerging Agents for Hepatorenal Syndrome by Nephrologists
doi : 10.1053/j.ajkd.2021.02.174
VOLUME 77, ISSUE 4, P619-620, APRIL 01, 2021
170 Success of Online CME at Improving Nephrologist Understanding of an Emerging Class of Drugs to Treat CKD-Anemia
doi : 10.1053/j.ajkd.2021.02.175
VOLUME 77, ISSUE 4, P620, APRIL 01, 2021
171 Success of Virtual Patient Simulation at Improving Management of Chronic Hyperkalemia
doi : 10.1053/j.ajkd.2021.02.176
VOLUME 77, ISSUE 4, P620, APRIL 01, 2021
172 APOL1 Genetic Testing in African American Patients With Hypertension: A Pilot Study of Attitudes and Perceptions
doi : 10.1053/j.ajkd.2021.02.177
VOLUME 77, ISSUE 4, P620-621, APRIL 01, 2021
173 Achievement of Partial Remission in Patient With ANCA-Associated Glomerulonephritis and Underlying Relapsing Polychondritis
doi : 10.1053/j.ajkd.2021.02.178
VOLUME 77, ISSUE 4, P621, APRIL 01, 2021
174 BK Virus Nephropathy in Native Kidney in a Patient With Recurrent T Cell Leukemia/Lymphoma
doi : 10.1053/j.ajkd.2021.02.179
VOLUME 77, ISSUE 4, P621, APRIL 01, 2021
175 Increased Use of Telemedicine by Inner-City Patients With Chronic Kidney Disease (CKD) and Kidney Transplants (KTX) During the COVID Pandemic
doi : 10.1053/j.ajkd.2021.02.180
VOLUME 77, ISSUE 4, P621-622, APRIL 01, 2021
176 Patients’ and Physicians’ Preferences for Treatment of Anemia of Chronic Kidney Disease: Design Methods of a Discrete Choice Experiment
doi : 10.1053/j.ajkd.2021.02.181
VOLUME 77, ISSUE 4, P622, APRIL 01, 2021
177 Racial Differences in Mortality Rates Among Elderly Non-ESRD CKD and ESRD Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD): Study Findings Using Data From the USRDS
doi : 10.1053/j.ajkd.2021.02.182
VOLUME 77, ISSUE 4, P622, APRIL 01, 2021
178 A Curious Case of Hypercalcemia
doi : 10.1053/j.ajkd.2021.02.183
VOLUME 77, ISSUE 4, P622-623, APRIL 01, 2021
180 Comparison of Engerix-B and Heplisav-B Vaccine Seroprotection Rates in Dialysis
doi : 10.1053/j.ajkd.2021.02.185
VOLUME 77, ISSUE 4, P623, APRIL 01, 2021
181 Medication Reconciliation in Hemodialysis Patients Associated With Reduced 30 Day Readmission
doi : 10.1053/j.ajkd.2021.02.186
VOLUME 77, ISSUE 4, P623-624, APRIL 01, 2021
182 Trends and Correlates of Peritonitis Diagnosis Among Peritoneal Dialysis Patients
doi : 10.1053/j.ajkd.2021.02.187
VOLUME 77, ISSUE 4, P624, APRIL 01, 2021
183 ADPKD Patient Perspectives on Diagnosis and Management
doi : 10.1053/j.ajkd.2021.02.188
VOLUME 77, ISSUE 4, P624, APRIL 01, 2021
184 Low Serum Bicarbonate Is Associated With Excess Mortality in Kidney Transplant Recipients
doi : 10.1053/j.ajkd.2021.02.189
VOLUME 77, ISSUE 4, P624-625, APRIL 01, 2021
185 Low Serum Bicarbonate Is Associated With Graft Failure in Kidney Transplant Recipients
doi : 10.1053/j.ajkd.2021.02.190
VOLUME 77, ISSUE 4, P625, APRIL 01, 2021
186 Acyclovir-Induced Encephalopathy in a Patient on Peritoneal Dialysis
doi : 10.1053/j.ajkd.2021.02.191
VOLUME 77, ISSUE 4, P625, APRIL 01, 2021
187 Acute Kidney Injury in COVID-19 Pediatric Patients: Analysis of the Virtual Pediatric Systems Data
doi : 10.1053/j.ajkd.2021.02.192
VOLUME 77, ISSUE 4, P625, APRIL 01, 2021
188 COVID-19 and Kidney Transplant Recipients: Immunosuppression Management and Outcomes
doi : 10.1053/j.ajkd.2021.02.193
VOLUME 77, ISSUE 4, P625-626, APRIL 01, 2021
189 Eculizumab Therapy for Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
doi : 10.1053/j.ajkd.2021.02.194
VOLUME 77, ISSUE 4, P626, APRIL 01, 2021
190 Late-Onset Encapsulating Peritoneal Sclerosis–A Case Report
doi : 10.1053/j.ajkd.2021.02.195
VOLUME 77, ISSUE 4, P626, APRIL 01, 2021
191 Comparison Between Handheld and Portable Ultrasound Analysis of B Lines Number in Hospitalized Patients Requiring Hemodialysis
doi : 10.1053/j.ajkd.2021.02.196
VOLUME 77, ISSUE 4, P626-627, APRIL 01, 2021
192 Predictors of ESA Use in the Non-Dialysis-Dependent Chronic Kidney Disease Population with Anemia
doi : 10.1053/j.ajkd.2021.02.197
VOLUME 77, ISSUE 4, P627, APRIL 01, 2021
193 Capmatinib-Induced Psuedo-AKI: A Case Report
doi : 10.1053/j.ajkd.2021.02.198
VOLUME 77, ISSUE 4, P627, APRIL 01, 2021
194 Defining the Cause, Urine Metabolic Risk Factors and Change Over Time for Patients With Significant Hyperoxaluria and Recurrent Nephrolithiasis
doi : 10.1053/j.ajkd.2021.02.199
VOLUME 77, ISSUE 4, P627-628, APRIL 01, 2021
195 Dysphagia, Dysphonia and Ecchymoses Following Temporary Hemodialysis Catheter Placement
doi : 10.1053/j.ajkd.2021.02.200
VOLUME 77, ISSUE 4, P628, APRIL 01, 2021
196 Urticaria With Membranoproliferative Crescentic Glomerulonephritis
doi : 10.1053/j.ajkd.2021.02.201
VOLUME 77, ISSUE 4, P628, APRIL 01, 2021
197 The Pathways Project: Improving Supportive Care for Patients Receiving Dialysis
doi : 10.1053/j.ajkd.2021.02.202
VOLUME 77, ISSUE 4, P629, APRIL 01, 2021
198 A Rare Case of Pseudomelanosis Duodeni in a Middle-Aged Male on a Novel Iron-Based Phosphate Binder
doi : 10.1053/j.ajkd.2021.02.203
VOLUME 77, ISSUE 4, P629, APRIL 01, 2021
199 A Rare Case of Transient Central Diabetes Insipidus Post Liver/Kidney Transplant
doi : 10.1053/j.ajkd.2021.02.204
VOLUME 77, ISSUE 4, P629, APRIL 01, 2021
200 Can Strongyloides Cause IgA Nephropathy?
doi : 10.1053/j.ajkd.2021.02.205
VOLUME 77, ISSUE 4, P629-630, APRIL 01, 2021
201 Overview of Recurrence of Focal Segmental Glomerulosclerosis in Renal Transplant Patients and Effectiveness of Preemptive Plasma Exchange and Rituximab in Preventing Recurrence
doi : 10.1053/j.ajkd.2021.02.206
VOLUME 77, ISSUE 4, P630, APRIL 01, 2021
202 A Broad Renal Genetic Panel Identifies the Unexpected: A Case of Nephronophthisis in Adult-Onset ESRD
doi : 10.1053/j.ajkd.2021.02.207
VOLUME 77, ISSUE 4, P630, APRIL 01, 2021
203 Pseudo-Normal: A Case Report of Disguised Hypocalcemia in the Setting of Pseudohypercalcemia
doi : 10.1053/j.ajkd.2021.02.208
VOLUME 77, ISSUE 4, P630-631, APRIL 01, 2021
204 Telemedicine for Pediatric Nephrology in the Age of COVID-19 and Beyond: Perspectives on Future Practices and Workflow Changes for Glomerular Disease Management.
doi : 10.1053/j.ajkd.2021.02.209
VOLUME 77, ISSUE 4, P631, APRIL 01, 2021
205 Novel Regimen for Refractory Primary Membranous Nephropathy
doi : 10.1053/j.ajkd.2021.02.210
VOLUME 77, ISSUE 4, P631, APRIL 01, 2021
206 Studying AKI in COVID-19 Patients in the ICU using Nephrocheck Biomarker
doi : 10.1053/j.ajkd.2021.02.211
VOLUME 77, ISSUE 4, P631-632, APRIL 01, 2021
207 The Importance of CYP2D6 Polymorphism in Acute Kidney Injury (AKI)
doi : 10.1053/j.ajkd.2021.02.212
VOLUME 77, ISSUE 4, P632, APRIL 01, 2021
208 The Kidney Diet Challenge: An Experiential Educational Experience
doi : 10.1053/j.ajkd.2021.02.213
VOLUME 77, ISSUE 4, P632, APRIL 01, 2021
209 Recognizing Pseudohyperkalemias to Prevent Unnecessary Dialysis
doi : 10.1053/j.ajkd.2021.02.214
VOLUME 77, ISSUE 4, P632-633, APRIL 01, 2021
210 Acute Renal Failure by Massive IVC Thromboses Treated With Mechanical Thrombectomy: A Case Report of Atypical Catastrophic Antiphospholipid Syndrome
doi : 10.1053/j.ajkd.2021.02.215
VOLUME 77, ISSUE 4, P633, APRIL 01, 2021
211 COVID-19 Among Hospitalized Patients With Kidney Disease: Experience at an Academic Medical Center
doi : 10.1053/j.ajkd.2021.02.216
VOLUME 77, ISSUE 4, P633-634, APRIL 01, 2021
212 Reducing Transplant Disparities for Spanish-Speaking Patients
doi : 10.1053/j.ajkd.2021.02.217
VOLUME 77, ISSUE 4, P634, APRIL 01, 2021
213 Alterations to Peritoneal Dialysis Prescriptions in the First 120 Days of Dialysis May Reduce the Risk of Attrition
doi : 10.1053/j.ajkd.2021.02.218
VOLUME 77, ISSUE 4, P634, APRIL 01, 2021
214 Malnutrition Inflammation Complex Syndrome: An Unusual Cause of Low Parathyroid Hormone Levels in Chronic Kidney Disease
doi : 10.1053/j.ajkd.2021.02.219
VOLUME 77, ISSUE 4, P634-635, APRIL 01, 2021
215 Roxadustat Consistently Improves Hemoglobin (Hb) Versus Placebo, Achieving Hb ?10 g/dL in Most Patients (Pts) With Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
doi : 10.1053/j.ajkd.2021.02.220
VOLUME 77, ISSUE 4, P635, APRIL 01, 2021
216 Central Diabetes Insipidus in a 25-Year-Old Male With a Suprasellar Mass
doi : 10.1053/j.ajkd.2021.02.221
VOLUME 77, ISSUE 4, P635-636, APRIL 01, 2021
217 Transplant Renal Artery Stenosis: An Important Cause of Early Graft Failure
doi : 10.1053/j.ajkd.2021.02.222
VOLUME 77, ISSUE 4, P636, APRIL 01, 2021
218 Understanding and Making the Most of the Centers for Disease Control and Prevention’s (CDC) Chronic Kidney Disease (CKD) Surveillance System
doi : 10.1053/j.ajkd.2021.02.223
VOLUME 77, ISSUE 4, P636, APRIL 01, 2021
219 Efficacy of Roxadustat Across Stages of Chronic Kidney Disease
doi : 10.1053/j.ajkd.2021.02.224
VOLUME 77, ISSUE 4, P636, APRIL 01, 2021
220 Risk of RBC Transfusion and Volume-Related Adverse Events in Patients With Dialysis-Dependent Chronic Kidney Disease: Pooled Results From Roxadustat Phase 3 Studies
doi : 10.1053/j.ajkd.2021.02.225
VOLUME 77, ISSUE 4, P637, APRIL 01, 2021
221 Avoiding Invasive Procedures for a Rare Kidney Mass: A Case of Rosai-Dorfman Disease
doi : 10.1053/j.ajkd.2021.02.226
VOLUME 77, ISSUE 4, P637, APRIL 01, 2021
222 Diagnosing a Rare but Life-Threatening Disease: Catastrophic Antiphospholipid Syndrome
doi : 10.1053/j.ajkd.2021.02.227
VOLUME 77, ISSUE 4, P637, APRIL 01, 2021
223 Epstein Barr Virus Associated Smooth Muscle Tumor in a Transplanted Liver in a Patient With Simultaneous Heart and Liver Transplant
doi : 10.1053/j.ajkd.2021.02.228
VOLUME 77, ISSUE 4, P637-638, APRIL 01, 2021
224 C3 Glomerulonephritis With Normal Complement Levels in an Elderly Patient
doi : 10.1053/j.ajkd.2021.02.229
VOLUME 77, ISSUE 4, P638, APRIL 01, 2021
225 Granulomatous Interstitial Nephritis With Necrotizing Arteriolitis Secondary to Allopurinol
doi : 10.1053/j.ajkd.2021.02.230
VOLUME 77, ISSUE 4, P638, APRIL 01, 2021
226 IgA Nephropathy in a Patient with Psoriasis: A True Association or Just a Coincidence?
doi : 10.1053/j.ajkd.2021.02.231
VOLUME 77, ISSUE 4, P638, APRIL 01, 2021
227 Gemcitabine-Induced Thrombotic Microangiopathy in Breast Cancer
doi : 10.1053/j.ajkd.2021.02.232
VOLUME 77, ISSUE 4, P639, APRIL 01, 2021
228 Unique Case of Refractory Metabolic Acidosis in Continuous Kidney Replacement Therapy
doi : 10.1053/j.ajkd.2021.02.233
VOLUME 77, ISSUE 4, P639, APRIL 01, 2021
229 Bartonella Endocarditis-Associated ANCA-Mediated Crescentic Glomerulonephritis
doi : 10.1053/j.ajkd.2021.02.234
VOLUME 77, ISSUE 4, P639, APRIL 01, 2021
230 Diabetic Fibrillosis With Superimposed Glomerulonephritis vs Fibrillary Glomerulonephritis (GN)
doi : 10.1053/j.ajkd.2021.02.235
VOLUME 77, ISSUE 4, P639-640, APRIL 01, 2021
231 High Anion Gap Metabolic Acidosis Caused by 5-Oxoprolinemia
doi : 10.1053/j.ajkd.2021.02.236
VOLUME 77, ISSUE 4, P640, APRIL 01, 2021
232 Monoclonal Gammopathy of Renal Significance (MGRS) Mimicking IgA Vasculitis
doi : 10.1053/j.ajkd.2021.02.237
VOLUME 77, ISSUE 4, P640, APRIL 01, 2021
233 Breathless and Blue: Dapsone Induced Methemoglobinemia
doi : 10.1053/j.ajkd.2021.02.238
VOLUME 77, ISSUE 4, P640-641, APRIL 01, 2021
234 Where Did the TMA Come From, Where Did It Go
doi : 10.1053/j.ajkd.2021.02.239
VOLUME 77, ISSUE 4, P641, APRIL 01, 2021
235 High Symptom Burden Among a Prospective Hemodialysis Cohort
doi : 10.1053/j.ajkd.2021.02.240
VOLUME 77, ISSUE 4, P641, APRIL 01, 2021
236 Case Report: Persistent Metabolic Alkalosis in a Hemodialysis Patient
doi : 10.1053/j.ajkd.2021.02.241
VOLUME 77, ISSUE 4, P641-642, APRIL 01, 2021
237 Coinfection With COVID-19 and Cytomegalovirus in Kidney Transplant Recipients–A Case Series
doi : 10.1053/j.ajkd.2021.02.242
VOLUME 77, ISSUE 4, P642, APRIL 01, 2021
238 Postpartum Thrombotic Microangiopathy and Acute Kidney Injury Caused by Incompatible Platelet Transfusions–A Case Report
doi : 10.1053/j.ajkd.2021.02.243
VOLUME 77, ISSUE 4, P642, APRIL 01, 2021
239 The Changing Pattern of Anticoagulant Use in Dialysis Patients
doi : 10.1053/j.ajkd.2021.02.244
VOLUME 77, ISSUE 4, P642-643, APRIL 01, 2021
240 A Tardy Effect of Angiogenesis Inhibitors Leading to Accelerated Kidney Failure
doi : 10.1053/j.ajkd.2021.02.245
VOLUME 77, ISSUE 4, P643, APRIL 01, 2021
241 A Long-term, Open-label Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Achieve Normal Serum Phosphorus in Patients With CKD on Dialysis (NORMALIZE)
doi : 10.1053/j.ajkd.2021.02.246
VOLUME 77, ISSUE 4, P643, APRIL 01, 2021
242 Sirolimus in C3 Glomerulonephritis (C3GN): Friend or Foe
doi : 10.1053/j.ajkd.2021.02.247
VOLUME 77, ISSUE 4, P643-644, APRIL 01, 2021
243 Lumasiran Lowered Urinary Oxalate in Patients With Primary Hyperoxaluria Type 1 Irrespective of Pyridoxine Use, Hydration Status, and Genotype in the Phase 3 Clinical Trial ILLUMINATE-A
doi : 10.1053/j.ajkd.2021.02.248
VOLUME 77, ISSUE 4, P644, APRIL 01, 2021
244 Belatacept and Sarcoidosis–A Unique Case of a Renal Transplant Recepient
doi : 10.1053/j.ajkd.2021.02.249
VOLUME 77, ISSUE 4, P644, APRIL 01, 2021
245 Monoclonal Gammopathy of Renal Significance in a Patient With Membranoproliferative Glomerulonephritis
doi : 10.1053/j.ajkd.2021.02.250
VOLUME 77, ISSUE 4, P644, APRIL 01, 2021
246 Nephrotic Syndrome in patient with Lyme Disease: Case Report
doi : 10.1053/j.ajkd.2021.02.251
VOLUME 77, ISSUE 4, P644-645, APRIL 01, 2021
247 Initial Management in an Erythropoetin Stewardship Program
doi : 10.1053/j.ajkd.2021.02.252
VOLUME 77, ISSUE 4, P645, APRIL 01, 2021
248 Long-term Durability of an Erythropoietin Stewardship Program
doi : 10.1053/j.ajkd.2021.02.253
VOLUME 77, ISSUE 4, P645, APRIL 01, 2021
249 Hypophosphatemia in a Patient With Anxiety-Induced Hyperventilation
doi : 10.1053/j.ajkd.2021.02.254
VOLUME 77, ISSUE 4, P645-646, APRIL 01, 2021
250 Fatal Disseminated Acanthamoeba Infection in a Kidney Transplant Recipient
doi : 10.1053/j.ajkd.2021.02.255
VOLUME 77, ISSUE 4, P646, APRIL 01, 2021
251 A Surprising Case of Flank Pain: Severe Hemorrhage of Massive Renal Angiomyolipomas
doi : 10.1053/j.ajkd.2021.02.256
VOLUME 77, ISSUE 4, P646, APRIL 01, 2021
252 Acute Development of Severe Hypercalcemia in an Immobilized End-Stage Kidney Disease Patient
doi : 10.1053/j.ajkd.2021.02.257
VOLUME 77, ISSUE 4, P647, APRIL 01, 2021
253 Tubulointerstitial Nephritis and Uveitis in a Patient With Systemic Sclerosis
doi : 10.1053/j.ajkd.2021.02.258
VOLUME 77, ISSUE 4, P647, APRIL 01, 2021
254 Nephrology and Palliative Care Collaboration to Elicit End of Life Treatment Preferences in Veterans With ESRD
doi : 10.1053/j.ajkd.2021.02.259
VOLUME 77, ISSUE 4, P647, APRIL 01, 2021
255 Inactive Status on the Kidney Transplant Waitlist is Associated With Neighborhood Poverty
doi : 10.1053/j.ajkd.2021.02.260
VOLUME 77, ISSUE 4, P647, APRIL 01, 2021
256 A New First! Crescentic Fibrillary Glomerulonephritis That Improved Spontaneously
doi : 10.1053/j.ajkd.2021.02.261
VOLUME 77, ISSUE 4, P648, APRIL 01, 2021
257 Characteristics and Outcomes of COVID-19 Patients Requiring Extracorporeal Membrane Oxygenator (ECMO) With and Without Continuous Renal Replacement Therapy (CRRT): A Case Series
doi : 10.1053/j.ajkd.2021.02.262
VOLUME 77, ISSUE 4, P648, APRIL 01, 2021
258 Atypical Case of ANCA-Associated Vasculitis
doi : 10.1053/j.ajkd.2021.02.263
VOLUME 77, ISSUE 4, P648, APRIL 01, 2021
259 Fibrillary Glomerulonephritis: An Insidious Disease
doi : 10.1053/j.ajkd.2021.02.264
VOLUME 77, ISSUE 4, P648-649, APRIL 01, 2021
260 Emphysematous Pyelonephritis as a Rare Initial Presentation of Adult-Onset Insulin-Requiring Diabetes With Ketoacidosis
doi : 10.1053/j.ajkd.2021.02.265
VOLUME 77, ISSUE 4, P649, APRIL 01, 2021
261 Unusual Case of Renal Tuberculosis in Patient With Unsuspecting Chronic Back Pain
doi : 10.1053/j.ajkd.2021.02.266
VOLUME 77, ISSUE 4, P649, APRIL 01, 2021
262 Mixed Cryoglobulinemic MPGN in a Patient With Primary Sj?gren's Syndrome (pSS) Complicated by IgM MGUS
doi : 10.1053/j.ajkd.2021.02.267
VOLUME 77, ISSUE 4, P649, APRIL 01, 2021
263 When ANCA-Associated Vasculitis Met COVID-19: A Case Report
doi : 10.1053/j.ajkd.2021.02.268
VOLUME 77, ISSUE 4, P650, APRIL 01, 2021
264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy
doi : 10.1053/j.ajkd.2021.02.269
VOLUME 77, ISSUE 4, P650, APRIL 01, 2021
265 Acute Decompensated Heart Failure Turns Out to Be Scleroderma Renal Crisis: A Case Report
doi : 10.1053/j.ajkd.2021.02.270
VOLUME 77, ISSUE 4, P650, APRIL 01, 2021
266 Breast Calciphylaxis 3 Days After Parathyroidectomy in a Dialysis Patient
doi : 10.1053/j.ajkd.2021.02.271
VOLUME 77, ISSUE 4, P650-651, APRIL 01, 2021
267 C1q Nephropathy With APOL1
doi : 10.1053/j.ajkd.2021.02.272
VOLUME 77, ISSUE 4, P651, APRIL 01, 2021
268 Initial Experience With Thrombectomy of EndoAVF Created by WavelinQ System
doi : 10.1053/j.ajkd.2021.02.273
VOLUME 77, ISSUE 4, P651, APRIL 01, 2021
269 Primary Hyperoxaluria Type 3 Can Also Result in End Stage Kidney Disease
doi : 10.1053/j.ajkd.2021.02.274
VOLUME 77, ISSUE 4, P651-652, APRIL 01, 2021
270 Seronegative Anti-Glomerular Basement Membrane Positive Lupus Nephritis
doi : 10.1053/j.ajkd.2021.02.275
VOLUME 77, ISSUE 4, P652, APRIL 01, 2021
271 Costoclavicular Compression
doi : 10.1053/j.ajkd.2021.02.276
VOLUME 77, ISSUE 4, P652, APRIL 01, 2021
272 Lisinopril-Induced Acute Pancreatitis in a Hemodialysis Patient
doi : 10.1053/j.ajkd.2021.02.277
VOLUME 77, ISSUE 4, P652, APRIL 01, 2021
273 Clinical Course of Bevacizumab-Associated Kidney Adverse Effects
doi : 10.1053/j.ajkd.2021.02.278
VOLUME 77, ISSUE 4, P652-653, APRIL 01, 2021
274 The Sign of the Four: A Case of IgG4-RD
doi : 10.1053/j.ajkd.2021.02.279
VOLUME 77, ISSUE 4, P653, APRIL 01, 2021
275 Association of Red Cell Distribution Width and Residual Kidney Function in Hemodialysis Patients
doi : 10.1053/j.ajkd.2021.02.280
VOLUME 77, ISSUE 4, P653, APRIL 01, 2021
276 Association of Systolic Blood Pressure and Residual Kidney Function Decline Among Hemodialysis Patients
doi : 10.1053/j.ajkd.2021.02.281
VOLUME 77, ISSUE 4, P653-654, APRIL 01, 2021
277 Evaluation of Potential Physicochemical Interactions of Orally Administered, Nonabsorbed Ion-Exchange Resins With Veverimer
doi : 10.1053/j.ajkd.2021.02.282
VOLUME 77, ISSUE 4, P654, APRIL 01, 2021
278 Minimal Change Disease After Hematopoietic Stem Cell Transplant
doi : 10.1053/j.ajkd.2021.02.283
VOLUME 77, ISSUE 4, P654, APRIL 01, 2021
279 Nocardia Farcinica Peritonitis in a Patient on Peritoneal Dialysis
doi : 10.1053/j.ajkd.2021.02.284
VOLUME 77, ISSUE 4, P654-655, APRIL 01, 2021
280 An Unusual Case of Paradoxical Refractory Hyperreninemic Hypertension Induced by Antihypertensive Medication
doi : 10.1053/j.ajkd.2021.02.285
VOLUME 77, ISSUE 4, P655, APRIL 01, 2021
281 Renal Allograft Malakoplakia Successfully Treated With Prolonged Antibiotic Therapy and Reduction of Immunosuppression
doi : 10.1053/j.ajkd.2021.02.286
VOLUME 77, ISSUE 4, P655, APRIL 01, 2021
282 Toxic Epidermal Necrosis as a Critical Clinical Clue in Methotrexate-Induced Acute Tubular Necrosis
doi : 10.1053/j.ajkd.2021.02.287
VOLUME 77, ISSUE 4, P655-656, APRIL 01, 2021
283 Uncommon Morphology of Common Calcium Oxalate Crystals Due to Urinary Supersaturation: A Case Report
doi : 10.1053/j.ajkd.2021.02.288
VOLUME 77, ISSUE 4, P656, APRIL 01, 2021
284 Development of a Conceptual Framework for Digital Medication Management Education for Chronic Kidney Disease
doi : 10.1053/j.ajkd.2021.02.289
VOLUME 77, ISSUE 4, P656, APRIL 01, 2021
285 Increasing Serum Bicarbonate Is Associated with Reduced Risk of Adverse Kidney Outcomes in Patients with CKD and Metabolic Acidosis
doi : 10.1053/j.ajkd.2021.02.290
VOLUME 77, ISSUE 4, P656-657, APRIL 01, 2021
286 Dialysis Modality and Hypertension at an Early Post-Kidney Transplant Period: A Propensity Score Weighting
doi : 10.1053/j.ajkd.2021.02.291
VOLUME 77, ISSUE 4, P657, APRIL 01, 2021
287 Real-World RAAS Inhibitor Dosing and Adherence in Patients on Patiromer
doi : 10.1053/j.ajkd.2021.02.292
VOLUME 77, ISSUE 4, P657, APRIL 01, 2021
288 An Unusual Presentation of Minimal Change Disease in a Middle-Aged Female
doi : 10.1053/j.ajkd.2021.02.293
VOLUME 77, ISSUE 4, P657-658, APRIL 01, 2021
289 Unilateral Ureteral Obstruction Causing Acute Kidney Injury
doi : 10.1053/j.ajkd.2021.02.294
VOLUME 77, ISSUE 4, P658, APRIL 01, 2021
290 Efficacy of Difelikefalin in Patients With Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Subgroup Analysis of KALM-1 and KALM-2
doi : 10.1053/j.ajkd.2021.02.295
VOLUME 77, ISSUE 4, P658, APRIL 01, 2021
291 Difficulties in Managing Renal Allograft Function in a Patient With Metastatic Squamous Cell Carcinoma Treated With Salvage Immunotherapy
doi : 10.1053/j.ajkd.2021.02.296
VOLUME 77, ISSUE 4, P658-659, APRIL 01, 2021
292 A Case of Lupus Nephritis Complicated by Noninflammatory Vasculopathy
doi : 10.1053/j.ajkd.2021.02.297
VOLUME 77, ISSUE 4, P659, APRIL 01, 2021
293 Post-operative Thrombotic Microangiopathy Causing Renal Failure
doi : 10.1053/j.ajkd.2021.02.298
VOLUME 77, ISSUE 4, P659, APRIL 01, 2021
294 Renal Vein Thrombosis in High-Grade Urothelial Carcinoma Without Nephrotic Syndrome
doi : 10.1053/j.ajkd.2021.02.299
VOLUME 77, ISSUE 4, P659-660, APRIL 01, 2021
295 Complementary Medicine (CAM) Beliefs and Attitudes Towards COVID-19 in Inner-City Kidney Patients
doi : 10.1053/j.ajkd.2021.02.300
VOLUME 77, ISSUE 4, P660, APRIL 01, 2021
296 Trust in State and Federal Public Health Guidelines for COVID-19 Among Inner-City Patients With Chronic Kidney Disease (CKD), End-Stage Kidney Disease (ESKD), and Kidney Transplant (KTx)
doi : 10.1053/j.ajkd.2021.02.301
VOLUME 77, ISSUE 4, P660, APRIL 01, 2021
297 Development of Media-Based Interventions to Increase African American Use of Living Donor Kidney Transplant Through Paired Exchanges
doi : 10.1053/j.ajkd.2021.02.302
VOLUME 77, ISSUE 4, P660, APRIL 01, 2021
298 Serial Microscopic Examination of the Urinary Sediment in Acute Kidney Injury Diagnosis and Prognostication
doi : 10.1053/j.ajkd.2021.02.303
VOLUME 77, ISSUE 4, P660-661, APRIL 01, 2021
299 Lessons Learned from A Case of Severe Hungry Bone Syndrome
doi : 10.1053/j.ajkd.2021.02.304
VOLUME 77, ISSUE 4, P661, APRIL 01, 2021
300 Assessment of Motivators for Racial/Ethnic Minority Kidney Patients and Caregivers’ Participation in Clinical Trials
doi : 10.1053/j.ajkd.2021.02.305
VOLUME 77, ISSUE 4, P661, APRIL 01, 2021
301 KIDNEYCODE: A Genetic Testing Program for Patients With Chronic Kidney Disease
doi : 10.1053/j.ajkd.2021.02.306
VOLUME 77, ISSUE 4, P661-662, APRIL 01, 2021
302 Engaging the Community on World Kidney Day
doi : 10.1053/j.ajkd.2021.02.307
VOLUME 77, ISSUE 4, P662, APRIL 01, 2021
303 Birds of a Feather: Do Home Dialysis Modalities Exhibit Regional Correlation?
doi : 10.1053/j.ajkd.2021.02.308
VOLUME 77, ISSUE 4, P662, APRIL 01, 2021
304 Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years
doi : 10.1053/j.ajkd.2021.02.309
VOLUME 77, ISSUE 4, P662-663, APRIL 01, 2021
305 Iatrogenic Arteriovenous Fistula With Central Venous Catheterization
doi : 10.1053/j.ajkd.2021.02.310
VOLUME 77, ISSUE 4, P663, APRIL 01, 2021
306 Risk of Acute Kidney Injury in COVID-19 is Increased in African Americans With APOL1 High-Risk Genotype
doi : 10.1053/j.ajkd.2021.02.311
VOLUME 77, ISSUE 4, P663, APRIL 01, 2021
307 Burden of Anemia in Patients With and Without Dialysis Dependent Chronic Kidney Disease: A Report From the Retrospective Cohort From DISCOVER CKD
doi : 10.1053/j.ajkd.2021.02.312
VOLUME 77, ISSUE 4, P663, APRIL 01, 2021
308 Characteristics of Patients With and Without Dialysis Dependent Chronic Kidney Disease and Anemia Receiving Blood Transfusions and Intravenous Iron: A Report From the DISCOVER CKD Retrospective Cohort
doi : 10.1053/j.ajkd.2021.02.313
VOLUME 77, ISSUE 4, P664, APRIL 01, 2021
309 Association of Willingness to Seek Care in the ED With Fear and Attitudes Concerning COVID-19 in Inner-City Kidney Patients
doi : 10.1053/j.ajkd.2021.02.314
VOLUME 77, ISSUE 4, P664, APRIL 01, 2021
310 A Case Report of Thin Basement Membrane with Proteinuria Associated with Complement 5 and Apolipoprotein L1 Variants in the Heterozygous State
doi : 10.1053/j.ajkd.2021.02.315
VOLUME 77, ISSUE 4, P664, APRIL 01, 2021
311 Acute Kidney Injury and Collapsing Glomerulopathy in Patient With COVID-19 and Homozygous for APOL1 Gene Variant
doi : 10.1053/j.ajkd.2021.02.316
VOLUME 77, ISSUE 4, P664-665, APRIL 01, 2021
312 Homozygous G2 APOL1 Allele and a Heterozygous Complement 5 Variant in Hypertensive Chronic Kidney Disease
doi : 10.1053/j.ajkd.2021.02.317
VOLUME 77, ISSUE 4, P665, APRIL 01, 2021
313 Homozygous High-Risk APOL1 Variant and Heterozygous COL4A4 Mutation in an African American Patient With Collapsing Focal Segmental Glomerulonephritis
doi : 10.1053/j.ajkd.2021.02.318
VOLUME 77, ISSUE 4, P665, APRIL 01, 2021
314 Medicare Coverage for Outpatient Dialysis for Acute Kidney Injury (AKI): Initial Uptake and Outcomes
doi : 10.1053/j.ajkd.2021.02.319
VOLUME 77, ISSUE 4, P665-666, APRIL 01, 2021
315 Acute Oxalate Nephrotoxicity Secondary to Starfruit Ingestion
doi : 10.1053/j.ajkd.2021.02.320
VOLUME 77, ISSUE 4, P666, APRIL 01, 2021
316 Shades of Congophilia–A Case of Fibrillary Glomerulonephritis
doi : 10.1053/j.ajkd.2021.02.322
VOLUME 77, ISSUE 4, P666, APRIL 01, 2021
Broken Tumor, Intact Courage
Dharam Kaushik, MD
doi : 10.1053/j.ajkd.2020.11.009
VOLUME 77, ISSUE 4, PA14-A15, APRIL 01, 2021
Recurrent Nephrolithiasis Causing Kidney Failure
Amy A. Yau/Judy Hindi/Jaime Uribarri
doi : 10.1053/j.ajkd.2020.04.020
VOLUME 77, ISSUE 4, PA18-A21, APRIL 01, 2021
